The costs of publication of this article were defrayed, in part, by the payment of page charges. This article must, therefore, be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Trans Fat Diet Induces Abdominal Obesity and Changes in Insulin Sensitivity in Monkeys
Article first published online: 6 SEP 2012
2007 North American Association for the Study of Obesity (NAASO)
Volume 15, Issue 7, pages 1675–1684, July 2007
How to Cite
Kavanagh, K., Jones, K. L., Sawyer, J., Kelley, K., Carr, J. J., Wagner, J. D. and Rudel, L. L. (2007), Trans Fat Diet Induces Abdominal Obesity and Changes in Insulin Sensitivity in Monkeys. Obesity, 15: 1675–1684. doi: 10.1038/oby.2007.200
Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- Issue published online: 6 SEP 2012
- Article first published online: 6 SEP 2012
- Received for review July 14, 2006, Accepted in final from January 05, 2007
- fatty acids;
- animal models;
- insulin resistance;
- Top of page
- Research Methods and Procedures
Objective: There is conflicting evidence about the propensity of trans fatty acids (TFAs) to cause obesity and insulin resistance. The effect of moderately high intake of dietary monounsaturated TFAs on body composition and indices of glucose metabolism was evaluated to determine any pro-diabetic effect in the absence of weight gain.
Research Methods and Procedures: Male African green monkeys (Chlorocebus aethiops; n = 42) were assigned to diets containing either cis-monounsaturated fatty acids or an equivalent diet containing the trans-isomers (∼8% of energy) for 6 years. Total calories were supplied to provide maintenance energy requirements and were intended to not promote weight gain. Longitudinal body weight and abdominal fat distribution by computed tomography scan analysis at 6 years of study are reported. Fasting plasma insulin, glucose, and fructosamine concentrations were measured. Postprandial insulin and glucose concentrations, and insulin-stimulated serine/threonine protein kinase (Akt), insulin receptor activation, and tumor necrosis factor-α concentrations in subcutaneous fat and muscle were measured in subsets of animals.
Results: TFA-fed monkeys gained significant weight with increased intra-abdominal fat deposition. Impaired glucose disposal was implied by significant postprandial hyperinsulinemia, elevated fructosamine, and trends toward higher glucose concentrations. Significant reduction in muscle Akt phosphorylation from the TFA-fed monkeys suggested a mechanism for these changes in carbohydrate metabolism.
Discussion: Under controlled feeding conditions, long-term TFA consumption was an independent factor in weight gain. TFAs enhanced intra-abdominal deposition of fat, even in the absence of caloric excess, and were associated with insulin resistance, with evidence that there is impaired post-insulin receptor binding signal transduction.
- Top of page
- Research Methods and Procedures
Production of partially hydrogenated vegetable oils containing trans fatty acids (TFAs)1 was developed because of their low cost, long shelf life, and suitability for commercial frying and transport. Partial hydrogenation, the industrial hardening of edible oils, causes some double bonds to be saturated, whereas others are changed from cis to trans configuration. The end products typically contain >20 new isomers of oleic and linoleic acids, which can make up 40% or more of the total fat (1). Elaidic acid (t18:1n9) is the major component of industrially produced monounsaturated TFAs (2). Natural sources of TFAs are milk, butter, and beef fat, produced by ruminant bacterial isomerases that can convert the double bonds of dietary fat into a trans configuration (3, 4, 5). Industrial processes produce much higher amounts of monounsaturated TFAs, which can be found in manufactured products such as margarine, shortenings, and fats used for frying (3).
Intake of TFAs is currently estimated at <7% of dietary fat and, on average, 3% of total energy intake (6, 7, 8, 9). The Food and Drug Administration has recognized the harmful effects of TFAs, and, as of 2006, a regulation was passed to enforce declaration of TFA content on the nutrition label of conventional foods and dietary supplements. The decision to regulate TFA labeling has been driven by extensive data showing TFA association with cardiovascular disease (10). Before this ruling, the U.S. and Canada did not require manufacturers to reveal the trans content of their products and allowed labeling as “low saturated fat” and “low in cholesterol” regardless of their trans fat content (1).
A diet high in fat content is a well-known risk factor for development of type 2 diabetes (T2DM) (11). The Nurse's Health Study provides epidemiologic evidence of increasing TFA intake and risk of T2DM (8, 12), and smaller studies in obese individuals and animals have shown increased insulin secretion after TFA ingestion (3, 13, 14). Data suggest that the incidence of T2DM would be reduced by >40% if these oils were consumed in their original, unhydrogenated form (8, 12). Conflicting evidence exists, however, with short-term intake of diets containing 5% to 9% TFAs having no adverse effects on insulin sensitivity and glucose metabolism (15, 16). Additionally, both the Health Professional's Follow-up Study and the Iowa Women's Health Study showed that there was no increase in risk of T2DM with increasing TFA intake when total energy intake, all fats consumed, and body weight were factored into analysis (17, 18).
TFA ingestion has been associated with the development of abdominal obesity (19), cardiovascular disease (20), and, in some studies, T2DM (8, 12). These conditions exist together in the newly defined metabolic syndrome (MS), which suggests that TFA intake may have an etiologic role in the generation of this syndrome. However, from 1980 to 1998, the average intake of TFAs decreased (5, 20), whereas the prevalence of obesity and T2DM is still increasing (21). In adults, T2DM is estimated to reach 5.4% of the population, or 300 million worldwide, in 2025 (22), indicating that quality of dietary fat is not likely to be the sole factor in the pathogenesis of T2DM. The aim of this study was to evaluate the effect of moderately high intake of dietary monounsaturated TFAs over a significant lifespan (∼15 years human equivalent) in young healthy adult monkeys on body composition and indices of glucose metabolism to determine any pro-diabetic effect in the absence of weight gain.
The use of a non-human primate permits long-term controlled evaluation of a nutritional intervention in a species that closely resembles humans in respect to fatty acid absorption and metabolism (23). Furthermore, the African green monkey has been shown to develop atherosclerosis as a consequence of a high-fat, cholesterol-supplemented diet in a more similar manner than is true for many other primate species (23, 24). The ability to model a chronic complex disease process such as atherosclerosis, which involves gastrointestinal, vascular, hepatic, and inflammatory physiology, lends support to the selection of this species and the ability to show dietary effects on body composition and insulin sensitivity that would be relevant to people.
Research Methods and Procedures
- Top of page
- Research Methods and Procedures
Adult male African green monkeys (Chlorocebus aethiops; n = 42; average age, 8 years; range, 4 to 13 years) sourced from St. Kitts island were included in this study that was primarily designed to evaluate dietary influences on atherosclerosis. Monkeys were housed inside, in individual cages, under climate-controlled conditions (70°F to 76°F; 40% to 60% humidity) with 12-hour light and dark cycles. They were assigned to groups, stratified by body weight and plasma lipids, to either diets containing primarily monounsaturated fatty acids in the cis conformation (CIS) or an equivalent diet (TRANS) containing a partial substitution of trans isomers for cis fatty acids. Experimental diets were fed for 6 years. Both diets were supplied at 70 kcal/kg per day, divided into morning and afternoon feedings, and the amount fed throughout the study was based on the body weight recorded at study initiation after equilibration to the laboratory environment had occurred. Body weight was monitored over time by weighing the monkeys no less than every 8 weeks. Calories supplied were calculated to provide maintenance energy requirements and were not intended to promote weight gain. Typically rations were completely consumed within 30 minutes of feeding. Study procedures were approved by the Institutional Animal Care and Use Committee of Wake Forest University.
Experimental diets were made in-house and contained fat as 35% kcal (energy), protein as 17% kcal, carbohydrate as 48% kcal, and cholesterol as 0.4 mg/kcal. The main dietary ingredients are listed in Table 1. Dietary fats were supplied from AC Humko Foods (Memphis, TN) as a TFA-enriched blend derived from nickel-catalyzed partially hydrogenated soybean oil or as an equivalent oleic acid-enriched blend of fatty acids. The dietary fatty acid percentage composition, indicating the degree of enrichment in monounsaturated TFAs, is shown in Table 2. TRANS contained ∼8% of energy as TFAs, which is within the upper limit of intake estimates for people. Although high, it is not unrealistic and was chosen to permit detection of effects. TFA content of the CIS diet was <1% of supplied energy (Table 3). Dietary content and composition of fatty acids were checked no less than every 8 weeks by gas chromatography (25). Chromatography was achieved by CP-SelectCB column (Varian, Palo Alto, CA) installed in a HP 5890 series II gas chromatograph equipped with an HP 7673 autosampler (Hewlett-Packard Company, Palo Alto, CA). The carrier gas is hydrogen at 20 pounds per square inch (psi), and chromatograms are plotted and peaks identified and integrated using ChromPerfect Spirit software (Justice Laboratory Software, Denville, NJ).
|Ingredient||Amount (g/100g diet)|
|Fat supplied as either CIS or TRANS blend*||16.7|
|Hegsted mineral salts mix IV†||5|
|Dietary fatty acid percentage compositions (w/w)|
|Dietary fatty acid percentage of supplied energy|
Monkeys were sedated at study initiation and termination (ketamine hydrochloride, 10 to 15 mg/kg, intramuscularly) for collection of blood samples. Plasma was assayed for fasting insulin (Mercodia, Uppsala, Sweden), glucose (Roche, Basel, Switzerland), fructosamine (Roche), and adiponectin (Linco Research, St. Charles, MO) concentrations in all monkeys. Assays for insulin and adiponectin were done using enzyme-linked immunosorbent assay methodology. Insulin had intra-assay and inter-assay coefficients of variability (CVs) of <10% and <5%, respectively. Adiponectin had both intra-assay and inter-assay CVs of <5%. Fructosamine and glucose assays were both colorimetric. Glucose measures had both intra-assay and inter-assay CVs of <5%. Fructosamine concentrations had an intra-assay CV of <15% and an inter-assay CV of <10%.
A subset (n = 12) were available at termination for the measurement of postprandial insulin concentrations where monkeys were given access to 50% of their daily caloric allotment for 90 minutes; any remaining food was removed, and blood samples were taken 3 hours later.
Monkeys (n = 34) were anesthetized between 68 and 73 months of study for computed tomography (CT) scanning and volumetric assessment of abdominal adipose tissue distribution. Scanning used a 16-slice General Electric Lightspeed Pro CT scanner (General Electric Healthcare, Waukesha, WI). CT scanning of the entire body using 0.625-mm slice collimation was performed, with the adipose volume calculated from the abdominal region as defined by the area between the level of the thoracolumbar junction and S1 vertebral body. Volumes of intra-abdominal, intramuscular, and subcutaneous fat volumes were calculated as previously described (26). Briefly, the abdominal section had a threshold of −140 to −40 CT units (i.e., Hounsfield units) applied to isolate the fat-containing voxels. Sections were manually traced for the intra-abdominal cavity every 1.5 cm, and the volume of fat voxels in the entire section was calculated. The procedure was repeated for manually tracing total fat (subcutaneous, intramuscular, and abdominal compartments) and tracing the body wall (abdominal and intramuscular compartments), and the individual volumes were calculated.
A randomly selected subset of animals (n = 9) was available for skeletal muscle and subcutaneous fat biopsy and measurement of waist circumference at study termination. Biopsies were collected under basal and insulin-stimulated conditions. Regular insulin was infused into a peripheral vein at 40 U/m2 per minute for 10 minutes, predicted to increase the average circulating insulin concentration to 100 μIU/mL (27). Insulin delivery was confirmed by measurement of capillary blood glucose from a toe stick (Precision QID Glucometer; Abbott Laboratories, Alameda, CA) and resulted in average glucose reduction of 20 mg/dL. Biopsy samples were frozen in liquid nitrogen and stored at −80°C until analysis. Protein was extracted from biopsy samples and analyzed for insulin receptor (IR) β subunit, total serine/threonine protein kinase (Akt), phosphorylated IR, and phosphorylated Akt according to manufacturer recommendations (Biosource, Camarillo, CA). Tumor necrosis factor α (TNF-α) was measured in protein isolated from fat biopsy tissue by enzyme-linked immunosorbent assay (Biosource, Camarillo, CA). TNF-α concentrations were not detectable in muscle extracts.
Results are presented as the mean ± standard error. Homeostasis model assessment ratios (HOMAs) were calculated from the product of insulin and glucose (mM/22.5) and used as an indicator of insulin resistance (28). Statistical comparisons were made by one-way ANOVA or analysis of covariance, if indicated, with significance set as α ≤ 0.05. Data were transformed if parameters did not satisfy normality assumptions before analysis. Non-parametric statistical comparisons were made for data associated with biopsy endpoints. All statistics were generated using Statistica 6 (StatSoft, Tulsa, OK).
- Top of page
- Research Methods and Procedures
Body weight at study initiation was comparable between the groups (p = 0.28). The mean body weight for the CIS group was 6.41 ± 0.12 kg, compared with 6.60 ± 0.11 kg for the TRANS group. Over the 6-year study period, body weight stabilized as expected secondary to being fed a caloric allowance aimed at weight maintenance (Figure 1). Despite the controlled feeding regimen, TRANS-fed monkeys still exhibited significant weight gain (p < 0.05; Table 4). The moderate but significant increase in weight at study termination (7% gain as opposed to <2% seen in the CIS group) was reflected by increases in both intra-abdominal and subcutaneous fat deposition, where TRANS fed monkeys had 33% greater and 29% greater fat volumes, respectively, measured in their abdominal region (Figures 2A and 3; Table 4) at the end of the 6-year study period. Although both fat volume compartments appeared to increase in the TRANS-fed group to a similar magnitude, the ratio of volumes was highly significantly different, indicating that TRANS-fed monkeys deposit more fat intra-abdominally for every cubic centimeter of fat gained than the CIS-fed monkeys, even when body weight was accounted for (Figure 2B; p = 0.018). This difference is shown in Figure 3, where monkeys matched on total body weight at study termination showed greater fat surrounding the viscera in the TRANS compared with the CIS subjects.
|N CIS/TRANS||CIS mean (SE)||TRANS mean (SE)||p|
|Body weight at study end||kg||20/21||6.55 (0.20)||7.00 (0.27)||0.049*|
|Body weight change from study initiation||%||20/21||1.78 (1.95)||7.20 (2.70)||0.049|
|Waist circumference||cm3||3/6||42.50 (2.01)||43.50 (5.20)||0.420|
|Intra-abdominal fat volume||cm3||17/17||178.41 (38.94)||237.60 (43.11)||0.110|
|Subcutaneous fat volume||cm3||17/17||138.07 (28.59)||177.46 (42.71)||0.330|
|Intramuscular fat volume||cm3||17/17||46.40 (12.05)||47.55 (10.73)||0.480|
|Intra-abdominal:subcutaneous fat volume||17/17||1.36 (0.09)||1.67 (0.14)||0.018*|
Measures of Carbohydrate Metabolism
There were no significant differences in the fasting measures of insulin and glucose or the index of insulin sensitivity calculated from these fasting measures (HOMA; Table 5) between the groups at the end of study; however, a non-significant tendency toward higher fasting glucose was noted in the TRANS-fed monkeys (p = 0.15). The TRANS-fed monkeys had significantly higher concentrations of fructosamine (p = 0.002) than CIS-fed monkeys. Only a subset of monkeys was available for measurement of insulin and glucose concentrations under non-fasted conditions; however, results (Figure 4) showed significant group differences in insulin concentrations. Glucose concentrations were similarly elevated between the groups, consistent with a postprandial state, but the insulin response was exaggerated in the TRANS-fed monkeys, where concentrations were >3-fold that of CIS (p = 0.015). Consistent with postprandial hyperinsulinemia representing an insulin- resistant state, postprandial insulin concentrations were highly associated with fructosamine (r = 0.71, p = 0.009). A relationship of glycemic control with intra-abdominal fat accumulation is suggested by the loss of significance in group fructosamine differences after addition of intra-abdominal fat as a covariate. Additionally, insulin resistance index was correlated with intra-abdominal fat volumes (Figure 5; r = 0.59, p < 0.001).
|N CIS/TRANS||CIS mean (SE)||TRANS mean (SE)||p*|
|Fasting insulin||μIU/mL||21/20||28.15 (4.35)||33.14 (4.77)||0.22|
|Fasting glucose||mg/dL||21/20||69.51 (2.61)||75.77 (5.37)||0.15|
|Fructosamine||mM||21/20||168.35 (3.71)||213.83 (14.72)||0.002|
|HOMA||21/20||5.26 (0.93)||6.50 (1.26)||0.15|
Insulin Receptor Signaling Efficacy
TRANS-fed monkeys showed significant reduction in muscle Akt activation with insulin stimulation (Table 6), because the phosphorylation amounts were nearly one quarter that of CIS (p = 0.02). No impairment in insulin receptor activation was detected in either fat or muscle, suggesting a post-receptor defect. TNF-α is known to interfere with Akt and insulin-receptor substrate phosphorylation and be elevated in obesity; however, this was not shown to be different between the CIS- and TRANS-fed animals evaluated. Results for fat concentrations are reported (Table 6) because muscle concentrations of TNF-α were too low to quantify.
|CIS mean (SE)||TRANS mean (SE)||p|
|Muscle insulin stimulated Akt phosphorylation||pg/mL/mg protein||22.4 (9.85)||5.86 (1.95)||0.020|
|Muscle insulin stimulated IR phosphorylation||U/mL/mg protein||0.22 (0.027)||0.19 (0.013)||0.30|
|Subcutaneous fat insulin stimulated Akt phosphorylation||pg/mL/mg protein||5.46 (1.66)||3.94 (1.85)||0.220|
|Subcutaneous fat insulin stimulated IR phosphorylation||U/mL/mg protein||0.16 (0.02)||0.18 (0.02)||0.300|
|Subcutaneous fat TNF-α||pg/mL/mg protein||10.38 (2.35)||6.36 (2.21)||0.300|
- Top of page
- Research Methods and Procedures
The major findings of this study showed that, in the absence of caloric excess, TFA induces greater weight gain over time, with enhanced intra-abdominal deposition of fat between the two groups as measured at study termination. There was evidence of impaired insulin sensitivity in the TFA group associated with abdominal obesity and reductions in insulin signal transduction efficiency at the post-receptor binding level compared with monkeys fed the unmodified fat diet at study end. The TFA diet models the trends seen in fats available in grocery stores, which have become more oleate rich and less TFA rich as canola oil has been increasingly substituted for partially hydrogenated soybean oil. Therefore, a comparison of cis- and trans-monounsaturates better represents the shift in the food fat composition that is already occurring in the U.S. The trans fat used in this study was partially hydrogenated soybean oil, which constitutes the major source (80% to 90%) of TFAs in the American diet (9).
The National Cholesterol Education Program's Adult Treatment Panel (NCEP ATP III) has identified the MS as a clustering of the metabolic complications of obesity (29). MS has significant public health implications because it is associated with a 6-fold increase in risk of developing T2DM (30). Diabetes is the fifth leading cause of death by disease and the leading cause of permanent disability in the U.S., accounting for more than one half of the national heath care expenditures (31). The age-adjusted rate for NCEP-defined MS in the U.S. population is currently 23.7% (30). With the current increasing trend in obesity and diabetes prevalence, these costs are predicted to increase, making study into contributing factors to MS imperative (21).
Our data signify that TFAs are an independent factor in weight gain and abdominal fat distribution, both of which are linked to MS. Our results are consistent with the NCEP ATP III analysis in that they both have shown a significant correlation of insulin resistance and central adiposity (30).
No other study has reported that an increase in TFA composition in diet, without increasing total caloric intake, can cause increased weight and abdominal fat deposition. Even though the increase in intra-abdominal fat did not reach statistical significance, the 33% gain in intra-abdominal fat volume is biologically significant. Semi-quantitative food-frequency questionnaires have suggested that increasing energy intake by 2% from TFAs, in substitution for carbohydrates and other fats, would be associated with a 0.77-cm waist gain over a 9-year period (19). Our results are consistent with this estimation and eliminate the inaccuracies that may result from survey methods. The lipogenic effect of TFAs is unknown, but interference with essential fatty acid desaturation and elongation and increases in fat cell size have been seen in rodent studies (32). It has been hypothesized that this interference alters the skeletal-muscle phospholipid composition that leads to insulin resistance and obesity (33).
Impaired glucose tolerance can be defined by post-glucose challenge 2-hour concentrations of 140 mg/dL. This leads to higher postprandial plasma glucose concentrations and is a known risk factor for the development of diabetes (34). Fructosamine is predominantly a measure of glycated plasma albumin, along with other circulating plasma proteins, and is indicative of the average glucose concentration to which these proteins are exposed. Fructosamine concentrations were significantly elevated with TFA feeding, which may suggest impairment of postprandial glucose disposal, because fasting glucose concentrations were comparable. The pattern for postprandial glucose concentrations in the TFA monkeys to be higher on average, although not reaching statistical significance, seems consistent with our observation of significantly elevated fructosamine concentrations. This abnormal handling of glucose is a result of insulin resistance as evidenced by significant postprandial hyperinsulinemia. The postprandial hyperinsulinemia seen is consistent with acute TFA effects observed in short-term studies (3, 13, 14). Furthermore insulin resistance contributes to hyperinsulinemia, secondary to the increased intra-abdominal adipose tissue, which is anatomically positioned close to the liver, implying greater flux of hepatic non-esterified fatty acids. This, in turn, could interfere with glucose oxidation and hepatic extraction of insulin (13, 14, 35).
It has been shown that higher fasting plasma glucose levels within the normal glycemic range constitutes an independent risk factor for T2DM among young men (36). Acknowledging this as a risk factor can promote early diagnosis of pre-diabetes and initiate efforts to reverse or delay its onset (34). Trends toward increased fasting glucose concentrations in TFA-fed animals and visceral adiposity were seen in this study. According to Tirosh et al. (36), these factors together enhance the risk of developing T2DM in a healthy male population.
Abdominal obesity is associated with insulin resistance and abnormal post-insulin receptor binding signal transduction. Akt is central in connecting signals from insulin receptor phosphorylation to the transport of glucose into the cell through glucose transporter-4 translocation to the cell membrane (37). Our results suggest that post-insulin receptor activation of Akt is impaired in muscle of monkeys fed a high-TFA diet. These data are consistent with the theory that defective Akt signaling is pivotal in the development of insulin resistance (37, 38). The significant impairment of Akt in muscle from TFA-fed monkeys contributes to this theory and is worth noting even in our small sample size. Decreased Akt activation, presumably causing decreased glucose import into muscle, may lead to an increase in circulating glucose concentrations and, over time, fructosamine levels, because skeletal muscle glucose uptake is the main determinant of whole body glucose disposal and insulin sensitivity.
TNF-α, an inflammatory adipokine, interferes with Akt phosphorylation through the production of ceramides (39). Limited data from this study suggest that the TFA-associated reduction in Akt activation was not through TNF-α, because TNF-α did not differ between diet groups. However, in this study, we did not expect to detect group differences in TNF-α because monkeys were not fed to induce obesity. Expanding adipocytes secrete more TNF-α, which leads to release of interleukin-6 and monocyte chemoattractant protein 1 from preadipocytes, endothelial cells, and resident macrophages. This results in significant recruitment of more macrophages and synergy in the release of inflammatory mediators and the induction of a pro-inflammatory state (40). TNF-α concentrations usually increase with obesity because there are more macrophages in adipose tissue as it accumulates (41). TNF-α has been proposed as a link between adiposity and the development of insulin resistance, because the majority of T2DM patients are obese and show increased TNF-α expression in fat cells (39, 41, 42). Furthermore, obese mice lacking TNF-α function have shown protection for developing insulin resistance (39).
This study was unique in that it directly compared the effects of controlled long-term TFA consumption with an equivalent cis-monounsaturated fatty acid diet in a relevant non-human primate model. The TFA consumption caused a 4-fold greater body weight gain despite being fed an individualized weight maintenance diet. Another strength of this study was the accurate body compositional analysis by CT, which allowed precision in determining fat depots. Most nutritional studies use surrogates for adiposity such as BMI and waist circumference. The TFA diet seemed to result in 30% more intra-abdominal fat deposited for every cubic centimeter of fat gained. Furthermore, the increase in intra-abdominal fat was significantly associated with insulin resistance (HOMA and fructosamine).
Several limitations arose throughout the study because the primary goal of the study design was to evaluate atherosclerosis (data to be presented elsewhere). Therefore, not all samples were collected appropriately for the measurement of insulin, and the entire study population was not available for every measurement. Our conclusions could have been strengthened by more sensitive measurements of carbohydrate metabolism such as glucose tolerance testing, hyperinsulinemic-euglycemic clamp methodology, or measuring glycated hemoglobin percentages, which indicate longer-term glycemic control (3 months compared with the 2 weeks that is estimated by fructosamine concentrations).
In conclusion, even in the absence of caloric excess and only very moderate gains in weight, the inclusion of TFA in the diet enhances abdominal obesity and induces abnormalities in glucose metabolism. Although much attention has been drawn to the adverse effects of TFAs on cardiovascular risk factors, little has been emphasized about the effects of consumption on the current “epidemic” of diabetes. The public health significance of TFA-rich diets and its potential contributions to T2DM and MS support the need for labeling requirements of restaurant foods, particularly fast food, where large amounts of TFAs are used in food preparation.
- Top of page
- Research Methods and Procedures
This work was supported by NIH Grant HL24736.
Nonstandard abbreviations: TFA, trans fatty acid; T2DM, type 2 diabetes; MS, metabolic syndrome; CIS, diet containing primarily monounsaturated fatty acids in the cis conformation; TRANS, diet containing a partial substitution of cis fatty acids for trans isomers; CV, coefficient of variation; CT, computed tomography; IR, insulin receptor; Akt, serine/threonine protein kinase; TNF-α, tumor necrosis factor-α; HOMA, homeostasis model assessment; NCEP ATP III, National Cholesterol Education Program's Adult Treatment Panel.
- Top of page
- Research Methods and Procedures
- 34American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29: (Suppl 1), S43–S48.